Advancing point-of-care diagnostics to the market
The 'Advancing point-of-care diagnostics to the market' program, under the Horizon Europe framework, is a research and innovation action designed to accelerate the development and market access of novel or improved point-of-care (POC) diagnostic devices for infectious diseases. It particularly focuses on addressing diagnostic gaps in sub-Saharan Africa, aiming to enhance healthcare quality and strengthen health systems in resource-limited communities. This initiative emphasizes clinical studies that lead to regulatory approval and broad availability of these essential health technologies.
Who is Funded
This section outlines the eligibility criteria for applicants, the geographic scope of the program, and its core objectives. It details which organizations and regions are targeted to ensure that funding supports the most impactful advancements in global health diagnostics.
What is Funded
This section provides details on the specific types of projects and thematic areas eligible for funding, focusing on point-of-care diagnostics. It also clarifies the typical developmental stage of supported innovations.
Type and Scope of Funding
This section details the nature of the financial support available, including the type of instrument and the maximum funding amount per project. It provides essential information for understanding the financial parameters of this funding opportunity.
Conditions and Requirements
This section outlines the critical rules and specific conditions that applicants and beneficiaries must adhere to throughout the program. It covers application terms, collaboration requirements, budget stipulations, and other important provisions.
Application Procedure
This section provides an overview of the application process, from submission requirements to the evaluation and selection procedures for funded projects. It ensures applicants understand the steps involved in securing funding.
Legal Basis
This section outlines the foundational legal and official documents that authorize and govern the funding program, ensuring transparency and adherence to established European Union regulations and policies.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
5.000.000 €
Allocated Budget:
56.000.000 EUR
Award Channel:
Framework Programme Call
Region:
European Union (Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden), Overseas Countries and Territories (Aruba, Bonaire, Curaçao, French Polynesia, French Southern and Antarctic Territories, Greenland, New Caledonia, Saba, Saint Barthélemy, Sint Eustatius, Sint Maarten, St. Pierre and Miquelon, Wallis and Futuna Islands), Horizon Europe Associated Countries (Albania, Armenia, Bosnia and Herzegovina, Faroe Islands, Georgia, Iceland, Israel, Kosovo, Moldova, Montenegro, North Macedonia, Norway, Serbia, Tunisia, Turkey, Ukraine), and sub-Saharan African EDCTP Association member countries (Burkina Faso, Cameroon, Congo, Côte d’Ivoire, Democratic Republic of the Congo, Ethiopia, Gabon, The Gambia, Ghana, Guinea, Kenya, Liberia, Malawi, Mali, Mozambique, Niger, Nigeria, Rwanda, Senegal, South Africa, Tanzania, Uganda, Zambia, Zimbabwe).
Sectors:
Healthcare, Medical Technology, Research and Development
Application Type:
Consortium Required
Funding Stages:
Experimental Development, Pilot Testing, Commercialization
Funding Provider
Program Level:
European Union
Funding Body:
European Commission, Global Health EDCTP3 Joint Undertaking
Managed By:
Global Health EDCTP3 Joint Undertaking
Additional Partners:
Industry (notably SMEs, especially African SMEs), local and international organisations.
Website: